帕金森病的药物治疗研究进展  

Progress of Drug Treatment for Parkinson’s Disease

作　　者：冯薇[1] 梁燕[1] FENG Wei;LIANG Yan(Dept.of Neurology,West China Hospital of Sichuan University,Chengdu 610000,China)

机构地区：[1]四川大学华西医院神经内科,成都610000

出　　处：《中国医院用药评价与分析》2025年第2期253-256,共4页Evaluation and Analysis of Drug-use in Hospitals of China

基　　金：四川大学华西护理学科发展专项基金项目(No.HXHL21042)

摘　　要：帕金森病是一种神经系统退行性疾病,发病率仅次于阿尔茨海默病,易导致患者出现心理疾病及其他运动症状,给患者及其家属带来极大的负担。随着医学的发展,人们逐渐认清帕金森病的发病机制,各种治疗手段层出不穷。目前,临床上治疗帕金森病以药物治疗为主。因此,本文就帕金森病的发病机制及国内外治疗帕金森病最新用药情况展开综述,为治疗帕金森病提供理论参考。Parkinson’s disease is a kind of degenerative disease of nervous system,second only to Alzheimer’s disease in terms of incidence,and is prone to mental illness and other motor symptoms,which brings great burden to patients and their families.With the development of medical science,the pathogenesis of Parkinson’s disease are explored.A variety of therapeutic means are emerging.At present,the clinical treatment of Parkinson’s disease mainly are drug treatment.Therefore,this paper reviews the pathogenesis of Parkinson’s disease and the latest medication in the treatment of Parkinson’s disease at home and abroad,so as to provide theoretical reference for the treatment of Parkinson’s disease.

关 键 词：帕金森病 药物治疗 研究进展 

分 类 号：R971[医药卫生—药品]